Ultrasound-assisted intrathecal injection of nusinersen in a patient with severe vertebral deformity: a case report

Abstract Background Spinal muscular atrophy (SMA) is a mostly autosomal recessive genetic disease characterized by progressive muscle weakness from anterior horn degeneration. Nusinersen has recently been approved as a disease-modifying drug for SMA that needs to be administered intrathecally. Its i...

Full description

Bibliographic Details
Main Authors: Takashi Nagano, Shinichi Sakura, Noritaka Imamachi, Yoji Saito
Format: Article
Language:English
Published: SpringerOpen 2020-08-01
Series:JA Clinical Reports
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40981-020-00367-y